Took me a minute... "Additionally, the Principa
Post# of 72440
"Additionally, the Principal Investigators for the Kevetrin trial have requested that the Company start preparing a presentation to be used for an article on the safety and pharmacological effect of Kevetrin on multiple cancer lines as demonstrated in the clinical trial. Cellceutix interprets this recommendation as a very optimistic sign regarding anticipated outcomes for the trial and clinical advancement of Kevetrin." -
See more at: http://cellceutix.com/cellceutix-reports-sple...KMP2s.dpuf